ISO Group Logo
Defense and Aerospace
Supply Chain Partner
A Dynatech International Company


NSN 6505-01-695-6725, 6505016956725
REMDESIVIR,INJECTION

Federal Supply Classification
FSC 6505 - Drugs and Biologicals
National Item Identification Number
NIIN 016956725
Codification Country
United States
Item Name Code
INC 80808
Criticality
(X) This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
Hazardous Material Indicator Code
(P) There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product.
Availability: Request Qualified Suppliers: Currently qualifying suppliers

Manufacture or supply this part?
Join our growing community of certified suppliers.

Let Us Know
  CALL ABOUT NSN 6505-01-695-6725
Our client representatives are standing by to help fulfill your request.

+1-321-773-5710

  REQUEST QUOTE for 6505-01-695-6725


Have a list that needs to be quoted? Upload it here.

DLMS® Summary

National Stock Number 6505-01-695-6725

National Stock Number (NSN) 6505-01-695-6725, or NIIN 016956725, (remdesivir,injection) was assigned June 17, 2021 in the Federal Logistics Information System (FLIS). This NIIN is Available for Manual Assignment. This NSN does not replace any other NSNs.

There are 3 manufacturer part numbers associated with this NSN. None of the associated part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by one supplier. Today, one supplier is listed as an Active supplier for this NSN. Of the active suppliers, only one supplier is deemed design controlled or valid supply parts.

This part number has not been procured by the US Government in over 5 years.

This NSN is assigned to Item Name Code (INC) 80808. [A VIRUS INHIBITOR, WHICH ADMINISTRATION IS INTRAVENOUS. IT'S A BROAD SPECTRUM ANTIVIRUS AGAINST CORONA VIRUSES LIKE MERS, SARS, COVID19.]. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product. NSN 6505016956725 does not contain precious metals.

This information was last updated on .


Technical Characteristics

ADMINISTRATION
(CSGS) INTRAVENOUS
PART NAME ASSIGNED BY CONTROLLING AGENCY
(CXCY) REMDESIVIR INJECTION, STERILE POWDER, 100MG VIAL
PRIMARY CONTAINER CONTENT QUANTITY
(CRLK) 100.0 MILLIGRAMS
PRIMARY CONTAINER TYPE
(CQCT) VIAL
SECONDARY CONTAINER TYPE
(CQGK) BOX
SPECIAL FEATURES
(FEAT) INDICATED FOR ADULTS AND PEDIATRIC PATIENTS (12 YEARS OF AGE AND OLDER AND WEIGHING AT LEAST 40 KG); FOR THE TREATMENT OF CORONAVIRUS DISEASE 2019 (COVID-19) REQUIRING HOSPITALIZATION; THE LYOPHILIZED FORMULATION NEEDS TO BE RECONSTITUTED AND THEN DILUTED INTO NORMAL SALINE IV INFUSION FLUIDS PRIOR TO USE; THE LYOPHILIZED POWDER CAN BE STORED BELOW 86F (30C) PRIOR TO USE. AFTER RECONSTITUTION, USE VIALS IMMEDIATELY TO PREPARE DILUTED SOLUTION; THE DILUTED SOLUTION IN THE INFUSION BAGS CAN BE STORED UP TO 24 HOURS AT ROOM TEMPERATURE 20 C TO 25 C (68 F TO 77 F) PRIOR TO ADMINISTRATION OR 48 HOURS AT REFRIGERATED TEMPERATURE 2 C TO 8 C (36 F TO 46 F); INTENDED FOR INTRAVENOUS ADMINISTRATION; SUPPLIED AS A SINGLE-DOSE VIAL CONTAINING A STERILE, PRESERVATIVE FREE WHITE TO OFF-WHITE TO YELLOW LYOPHILIZED POWDER; 100 MG; DISCARD UNUSED PORTION.

Manufacturer Part Numbers


Related Inventory



 
Top